Soligenix Short Long Term Debt Total Over Time
| SNGX Stock | USD 3.33 0.01 0.30% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Soligenix Performance and Soligenix Correlation. Soligenix |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soligenix. If investors know Soligenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soligenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.44) | Revenue Per Share 0.305 | Quarterly Revenue Growth (0.99) | Return On Assets (0.45) | Return On Equity (1.40) |
The market value of Soligenix is measured differently than its book value, which is the value of Soligenix that is recorded on the company's balance sheet. Investors also form their own opinion of Soligenix's value that differs from its market value or its book value, called intrinsic value, which is Soligenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soligenix's market value can be influenced by many factors that don't directly affect Soligenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soligenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Soligenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soligenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Short Long Term Debt Total Analysis
Compare Soligenix and related stocks such as Zura Bio Limited, Apexigen, and Phio Pharmaceuticals Corp Short Long Term Debt Total Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZURA | 355.6 K | 355.6 K | 355.6 K | 355.6 K | 355.6 K | 355.6 K | 355.6 K | 355.6 K | 355.6 K | 355.6 K | 355.6 K | 355.6 K | 355.6 K | 320 K | 284.5 K |
| PHIO | 534 K | 534 K | 5 K | 518 K | 518 K | 518 K | 518 K | 518 K | 518 K | 518 K | 642 K | 295 K | 305 K | 35 K | 33.2 K |
| IMMX | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 50 K | 50 K | 45 K | 42.8 K |
| ADXN | 126.6 K | 550.2 K | 550.2 K | 550.2 K | 550.2 K | 550.2 K | 550.2 K | 550.2 K | 550.2 K | 550.2 K | 567.4 K | 482 K | 373.1 K | 344.3 K | 448 K |
| ATXI | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 6.8 M | 5.4 M |
| PALI | 28.4 K | 7.7 M | 7.7 M | 7.7 M | 8.8 M | 8 M | 3.7 M | 180.9 K | 180.9 K | 180.9 K | 1.4 M | 199 K | 404 K | 369 K | 350.6 K |
| ALLR | 963 K | 963 K | 963 K | 963 K | 963 K | 963 K | 963 K | 963 K | 963 K | 963 K | 1.8 M | 1.1 M | 3.7 M | 1.3 M | 2 M |
| CNSP | 121.8 K | 121.8 K | 121.8 K | 121.8 K | 121.8 K | 121.8 K | 121.8 K | 121.8 K | 316.9 K | 439.3 K | 439.3 K | 387.8 K | 410 K | 300.8 K | 362.4 K |
| WINT | 100 K | 981 K | 660 K | 18.5 M | 20.4 M | 25.2 M | 25 M | 15 M | 23 M | 20.5 M | 3.8 M | 2.9 M | 2.3 M | 16.8 M | 9.8 M |
| DRMA | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 3.5 M | 3.5 M | 3.5 M | 4.1 M | 2.7 M |
| ENSC | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 5.1 M | 17.2 M | 4.4 M | 854.7 K | 812 K |
Soligenix and related stocks such as Zura Bio Limited, Apexigen, and Phio Pharmaceuticals Corp Short Long Term Debt Total description
My Equities
My Current Equities and Potential Positions
| Soligenix | SNGX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | New Jersey; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.33
Additional Tools for Soligenix Stock Analysis
When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.